Te Ira Tangata: a Zelen randomised controlled trial of a treatment package including problem solving therapy compared to treatment as usual in Maori who present to hospital after self harm

Simon Hatcher, Nicole Coupe, Mason Durie, Hinemoa Elder, Rees Tapsell, Karen Wikiriwhi, Varsha Parag, Simon Hatcher, Nicole Coupe, Mason Durie, Hinemoa Elder, Rees Tapsell, Karen Wikiriwhi, Varsha Parag

Abstract

Background: Maori, the indigenous people of New Zealand, who present to hospital after intentionally harming themselves, do so at a higher rate than non-Maori. There have been no previous treatment trials in Maori who self harm and previous reviews of interventions in other populations have been inconclusive as existing trials have been under powered and done on unrepresentative populations. These reviews have however indicated that problem solving therapy and sending regular postcards after the self harm attempt may be an effective treatment. There is also a small literature on sense of belonging in self harm and the importance of culture. This protocol describes a pragmatic trial of a package of measures which include problem solving therapy, postcards, patient support, cultural assessment, improved access to primary care and a risk management strategy in Maori who present to hospital after self harm using a novel design.

Methods: We propose to use a double consent Zelen design where participants are randomised prior to giving consent to enrol a representative cohort of patients. The main outcome will be the number of Maori scoring below nine on the Beck Hopelessness Scale. Secondary outcomes will be hospital repetition at one year; self reported self harm; anxiety; depression; quality of life; social function; and hospital use at three months and one year.

Discussion: A strength of the study is that it is a pragmatic trial which aims to recruit Maori using a Maori clinical team and protocol. It does not exclude people if English is not their first language. A potential limitation is the analysis of the results which is complex and may underestimate any effect if a large number of people refuse their consent in the group randomised to problem solving therapy as they will effectively cross over to the treatment as usual group. This study is the first randomised control trial to explicitly use cultural assessment and management.

Trial registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12609000952246.

References

    1. Beautrais AL, Wells JE, McGee MA, Oakley Browne MA. Suicidal behaviour in Te Rau Hinengaro: The New Zealand Mental Health Survey. Aust N Z J Psychiatry. 2006;40(10):896–904.
    1. Ministry of Health. Suicide Facts: Deaths and intentional self-harm hospitalisations 2008. Wellington: Ministry of Health; 2010.
    1. Hawton K, Zahl D, Weatherall R. Suicide following deliberate self-harm: long-term follow-up of patients who presented to a general hospital. Br J Psychiatry. 2003;182:537–542.
    1. Hawton K, Arensman E, Townsend E, Bremner S, Feldman E, Goldney R, Gunnell D, Hazell P, van Heeringen K, House A. et al.Deliberate self harm: systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition. Bmj. 1998;317(7156):441–447.
    1. Carter GL, Clover K, Whyte IM, Dawson AH, D'Este C. Postcards from the EDge project: randomised controlled trial of an intervention using postcards to reduce repetition of hospital treated deliberate self poisoning. Bmj. 2005;331(7520):805.
    1. Beautrais AL, Gibb SJ, Faulkner A, Fergusson DM, Mulder RT. Postcard intervention for repeat self-harm: randomised controlled trial. The British Journal of Psychiatry. 2010;197(1):55–60.
    1. Townsend E, Hawton K, Altman DG, Arensman E, Gunnell D, Hazell P, House A, Van Heeringen K. The efficacy of problem-solving treatments after deliberate self-harm: meta-analysis of randomized controlled trials with respect to depression, hopelessness and improvement in problems. Psychol Med. 2001;31(6):979–988.
    1. Hawton K, Townsend E, Arensman E, Gunnell D, Hazell P, House A, van Heeringen K. Psychosocial versus pharmacological treatments for deliberate self harm. Cochrane Database Syst Rev. 2000. p. CD001764.
    1. Hawton K, Harriss L, Zahl D. Deaths from all causes in a long-term follow-up study of 11,583 deliberate self-harm patients. Psychol Med. 2006;36(3):397–405.
    1. Ostamo A, Lonnqvist J. Excess mortality of suicide attempters. Social Psychiatry & Psychiatric Epidemiology. 2001;36(1):29.
    1. Knowles ML, Gardner WL. Benefits of membership: the activation and amplification of group identities in response to social rejection. Personality & Social Psychology Bulletin. 2008;34(9):1200–1213.
    1. Pollock LR, Williams JM. Effective problem solving in suicide attempters depends on specific autobiographical recall. Suicide and Life Threatening Behavior. 2001;31(4):386–396.
    1. Conner KR, Britton PC, Sworts LM, Joiner TE. Suicide attempts among individuals with opiate dependence: The critical role of belonging. Addictive Behaviors. 2007;32:1395–1404.
    1. Fujiwara T, Kawachi I. Social capital and health. A study of adult twins in the U.S.[see comment] American Journal of Preventive Medicine. 2008;35(2):139–144.
    1. Kember D, Hong C, Ho A. Characterizing the motivational orientation of students in higher education: a naturalistic study in three Hong Kong universities. British Journal of Educational Psychology. 2008;78(Pt 2):313–329.
    1. Chao SY, Lan YH, Tso HC, Chung CM, Neim YM, Clark MJ. Predictors of psychosocial adaptation among elderly residents in long-term care settings. Journal of Nursing Research. 2008;16(2):149–159.
    1. Zelen M. A new design for randomized clinical trials. New England Journal of Medicine. 1979;300:1242–1245.
    1. Adamson J, Cockayne S, Puffer S, Torgerson DJ. Review of randomised trials using the post-randomised consent (Zelen's) design. Contemp Clin Trials. 2006;27(4):305–319.
    1. Hawton K, Bergen H, Casey D, Simkin S, Palmer B, Cooper J, Kapur N, Horrocks J, House A, Lilley R. et al.Self-harm in England: a tale of three cities. Multicentre study of self-harm. Social Psychiatry & Psychiatric Epidemiology. 2007;42(7):513–521.
    1. Durie M. Launching Maori Futures. Wellington: Huia Publishers; 2003.
    1. D'Zurilla TJ, Goldfried MR. Problem solving and behaviour modification. J Abnorm Psychol. 1971;78:107–126.
    1. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the Hopelessness Scale. J Consult Clin Psychol. 1974;42(6):861–865.
    1. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361–370.
    1. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Annals of Internal Medicine. 2001;33:337–343.
    1. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Mdical Care. 1992;30(6):473–483.
    1. Hagerty BM, Patusky K. Developing a measure of sense of belonging. Nurs Res. 1995;44(1):9–13.
    1. Durie MH, Black TE, Christensen IS, Durie AE, Fitzgerald ED, Taiapa JT. Te Hoe Nuku Roa framework: A Maori identity measure. Journal of Polynesian Society. 1995;104(4)
    1. Beck AT, Schuyler D, Herman I. In: The Prediction of Suicide. Beck AT, Resnick HLP, Lettieri DJ, editor. Philadelphia: Charles Press; 1974. Development of suicidal intent scales.
    1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: new guidance. Medical research Council. 2008.
    1. Zotti AM, Omarini G, Ragazzoni P. Can the type of organisational structure affect individual well-being in health and social welfare occupations? Giornale Italiano di Medicina del Lavoro Ed Ergonomia. 2008;30(1 Suppl A):A44–51.
    1. Hewitt CE, Torgerson D, Miles JNV. Is there another way to take account of non-compliance in randomized controlled trials? CMAJ. 2006;175:347–348.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する